Search

Your search keyword '"Walsh, Garrett L."' showing total 221 results

Search Constraints

Start Over You searched for: Author "Walsh, Garrett L." Remove constraint Author: "Walsh, Garrett L." Database Unpaywall Remove constraint Database: Unpaywall
221 results on '"Walsh, Garrett L."'

Search Results

1. Early Interventional Treatment of High Output Chyle Leak following Esophagectomy is Associated with Improved Survival

2. Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases

3. Circulomic variables predict pathologic staging preoperatively in treatment-naïve non-small cell lung cancer

4. Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer

5. Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer

6. Factors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival

7. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease

8. Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy

9. Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery

10. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma

11. Disparities in early-stage lung cancer outcomes at minority serving hospitals compared to non-minority serving hospitals

12. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

13. Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers

14. Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer

15. Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients

16. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation

17. The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era

18. Repeated Pulmonary Metastasectomy: Third Operations and Beyond

19. Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer

20. 1016: HIGH-RISK FEATURES OF ESOPHAGEAL ADENOCARCINOMA FOLLOWING NEOADJUVANT CHEMORADIATION: PATIENTS FOR WHOM SURGERY SHOULD NOT BE DELAYED

21. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer

22. Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes

23. Lung Cancer

24. Contributors

25. Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection

26. Brief Report: Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer

27. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma

29. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy

30. Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients

31. Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy

32. Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients

33. Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications

34. Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy

35. Pulmonary resection for tissue harvest in adoptive tumor‐infiltrating lymphocyte therapy: Safety and feasibility

38. Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation

39. Predictors of survival following surgical resection of limited-stage small cell lung cancer

41. Contributors

42. Lung Cancer

43. Contributors

44. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

45. Ketorolac use and anastomotic leak in patients with esophageal cancer

47. Contributors

48. Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy

50. Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively

Catalog

Books, media, physical & digital resources